Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 466301 - 466320 out of 476583 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PSORIASIS- | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PSORIASIS-UVEITIS | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PSORIASIS-UVEITIS | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO(CF) 40MG/0.4ML INJ,PEN,CROHN-UC-H | 6X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO(CF) 40MG/0.4ML INJ,PEN,CROHN-UC-H | 6X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ,PEN,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ,PEN,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ,SYR,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC16) guselkumab (adm: P) | TREMFYA 100MG/ML INJ,SYR,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L04AC17) tildrakizumab (adm: P) | ILUMYA 100MG/ML INJ,SYRINGE,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaceuticalIndustries,Inc. |
| USA | (L04AC17) tildrakizumab (adm: P) | ILUMYA 100MG/ML INJ,SYRINGE,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaceuticalIndustries,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AJ03) pegcetacoplan (adm: P, previous atc code l04aa54. new atc 4th level l04aj valid from january 2024.) | EMPAVELI 1080MG/20ML INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | APLSalesILLC |
Pages
